Paul Daruwala, Chief Operating Officer at Cidara Therapeutics, Inc. (CDTX), sold 5,133 shares at $1.25 ($6K) on 2022-01-05, disclosed to the SEC on 2022-01-07.
Open-market sale of $6k CDTX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDTX | SELL | 2020-06-25 | $3K | — | Filing → |
| CDTX | SELL | 2020-01-06 | $8K | — | Filing → |
| CDTX | SELL | 2019-10-03 | $6K | — | Filing → |